AlphaGrep UK’s Balchem Corp BCPC Stock Holding History

AlphaGrep UK’s Portfolio BCPC Stock Details BCPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,370	Closed	-$232K	–	995
2026 Q1	$232K	Buy	+1,370	New	+$233K	0.07%	643

Other funds holding BCPC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AlphaGrep UK's BCPC Position: Q2 2026 in Review

AlphaGrep UK sold out of Balchem Corp (BCPC) in Q2 2026, closing a stake of 1,370 shares — an estimated $232K sold.

AlphaGrep UK first reported a position in BCPC in Q1 2026 and held it in 1 quarter. The position peaked at $232K in Q1 2026. 391 funds tracked by Wall St. Rank hold BCPC as of Q2 2026.

AlphaGrep UK reported no remaining Balchem Corp position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 1,370 Balchem Corp shares in Q2 2026, an estimated $232K.
AlphaGrep UK first reported a position in Balchem Corp in Q1 2026 and held it in 1 quarter.
AlphaGrep UK's Balchem Corp position peaked at $232K in Q1 2026.
391 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.